About UBS ETF (CH) - SMI ETF -CHF dis-

SMICHA invests in stocks. The fund's major sectors are Health Technology, with 36.40% stocks, and Finance, with 21.80% of the basket. The assets are mostly located in the Europe region.

SMICHA top holdings are Novartis AG and Nestle S.A., occupying 15.29% and 14.78% of the portfolio correspondingly.

SMICHA last dividends amounted to 0.32 CHF. The year before, the issuer paid 1.20 CHF in dividends, which shows a 275.00% decrease.

SMICHA assets under management is ‪2.87 B‬ CHF. It's fallen 2.20% over the last month.

SMICHA fund flows account for ‪312.19 M‬ CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

SMICHA shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Dec 2, 2003, and its management style is Passive.

SMICHA expense ratio is 0.20% meaning you'd have to pay 0.20% of your investment to help manage the fund.

SMICHA follows the Switzerland SMI. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

SMICHA invests in stocks.

SMICHA price has fallen by −1.80% over the last month, and its yearly performance shows a 1.63% increase. See more dynamics on SMICHA price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.98% over the last month, have fallen by −0.98% over the last month, showed a 1.82% increase in three-month performance and has increased by 3.28% in a year.